Also Read | Apollo Hospital MD on her Covid treatment: 'Cocktail therapy made a dramatic difference'Novavax CEO and President Stanley C.
Erck said that Novavax was one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines."These clinical results reinforce that NVX-CoV2373 is extremely effective and offers complete protection against both moderate and severe COVID-19 infection," he said.Also Read | Covaxin trials on children aged 6-12: AIIMS Delhi to start recruitment from tomorrowThe company said that it "intends to file for regulatory authorizations in the third quarter, upon completion of the final phases of process qualification and assay validation needed to meet chemistry,.